top of page

Weight Loss

There are multiple weight loss products available on the market and the most proven class of medications are GLP-1s (Glucagon-Like Peptide-1 agonists). GLP-1s  are a class of medications designed to aid weight loss by mimicking the natural hormone GLP-1, which regulates appetite and blood sugar levels. However, we aren’t your typical weight loss clinic that focuses solely on weight, which consists of fat, muscle, bone density and water.  We take a holistic approach by intermixing peptides into your weight loss program to transition fat to muscle, while preserving your body composition. 

  • Reduces appetite and promotes a feeling of fullness

  • Helps control blood sugar levels

  • Encourages steady, sustainable weight loss

  • Improves metabolic health

  • May reduce the risk of obesity-related conditions such as type 2 diabetes and cardiovascular disease

Using GLP-1s for weight loss can effectively support your journey towards a healthier weight and improved overall well-being. 


Tirzepatide contributes to weight loss through multiple mechanisms linked to its dual hormone action. Firstly, by mimicking GLP-1 (glucagon-like peptide-1), it enhances feelings of fullness and satiety, leading to reduced appetite and lower calorie intake. Secondly, as a GIP (glucose-dependent insulinotropic polypeptide) agonist, it possibly enhances the body’s energy expenditure. Tirzepatide also slows down gastric emptying, which prolongs the feeling of fullness after meals. These combined effects help individuals reduce their food intake and potentially increase calorie burning, contributing to significant weight loss, as observed in clinical studies. This makes tirzepatide an effective treatment option for managing both type 2 diabetes and obesity.

Recent studies have shown that patients lose an average of 20.9% of their body weight using Tirzepatide. With some noticeable weight loss in the first month, the full benefits are evident after 3–6 months of treatment.

Get started by filling out the contact form below!


Semaglutide is a medication used for the treatment of type 2 diabetes and, more recently, for weight management in adults. It belongs to a class of drugs known as GLP-1 receptor agonists, which mimic the action of the naturally occurring hormone GLP-1, enhancing insulin secretion and suppressing glucagon secretion. Semaglutide promotes weight loss primarily through its action on appetite regulation centers in the brain. As a GLP-1 receptor agonist, it mimics the effects of the naturally occurring hormone glucagon-like peptide-1 (GLP-1), which plays a role in appetite and food intake. By activating GLP-1 receptors in the brain, semaglutide increases feelings of fullness and satiety while reducing hunger. This leads to a decrease in overall calorie intake, supporting weight loss. Additionally, semaglutide may slow gastric emptying, further contributing to increased feelings of fullness after eating. These effects combined help individuals reduce their food intake and manage their weight more effectively.

Recent studies have shown an average weight loss of 14.9% of a patient’s initial body weight when using Semaglutide. With some noticeable weight loss in the first month, the full benefits are evident after 3-6 months of treatment.

bottom of page